Literature DB >> 712870

A new noninvasive method for the simultaneous determination of cardiac output, VA/QC disparity, and the magnitude of peripheral perfusion, suitable for use in the critically ill patient.

F H Geisler, E J Farrell, J H Siegel.   

Abstract

A noninvasive technique for determining cardiac output, lung blood-tissue volume, and the volume of perfused body tissue in shock states has been developed from analysis of the pulmonary washout of several physiologically inert tracer gases. Canine preparations and a computer-based simulation were used to evaluate the accuracy and feasibility of the technique. The dogs were ventilated with 10% helium, 10% N2O, 0.45% C2H2, 39.5% N2, and 40% O2 mixture, and washed out with 60% N2 and 40% O2. End-tidal volume excretion differences between the three inert gases helium, N2O, and C2H2 resulted from differences in the blood/gas partition constants (lambda) of the test gases. Helium, which has a very low lambda, is contained in lung air space, whereas N2O and C2H2, with moderate lambda's, are distributed to lung air space, blood, and perfused tissues. Computer modeling of the cardiopulmonary and body perfusion gas transport permitted calculation of alveolar ventilation, VA/VA disparity, pulmonary blood-tissue volume, pulmonary blood flow, VAQć, and perfused body volume in the canine experiments. In experimental shock settings and in a variety of control situations over an eightfold range of flows the pulmonary blood flow calculated from the N2O and C2H2 washout was generally within +/- 15% of the cardiac output determined by the cardiogreen technique.

Entities:  

Mesh:

Year:  1978        PMID: 712870     DOI: 10.1097/00005373-197811000-00001

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  1 in total

1.  A multipatient mass spectrometer based system for the measurement of metabolic gas exchange in artificially ventilated intensive care patients.

Authors:  M J Roberts; M L Boustred; C J Hinds
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.